Category Name Cardio-Diabetic — Oral Antidiabetic Combination (DPP-4 Inhibitor + Biguanide)
Common Indications Megnumet-50/500 Tablet is used in the management of:
- Type 2 Diabetes Mellitus in adults where blood sugar levels are not adequately controlled by diet, exercise, or single-agent therapy alone
- Reduction of elevated fasting and post-meal (postprandial) blood glucose levels
- Long-term glycemic control to help prevent serious diabetes-related complications such as kidney damage (nephropathy), vision loss (retinopathy), and nerve damage (neuropathy)
- Reduction of the risk of cardiovascular events such as heart attack and stroke in patients with Type 2 diabetes
- As an adjunct to a healthy diet and regular physical activity as part of a comprehensive diabetes management plan
This medicine is not indicated for Type 1 Diabetes Mellitus or diabetic ketoacidosis.
Common Dosing
- Standard Adult Dose: One tablet twice daily, with meals, or as prescribed by your doctor
- Timing: Best taken with food to reduce gastrointestinal side effects associated with Metformin
- Dose Adjustment: Your doctor will determine the appropriate dose and frequency based on your current blood glucose levels, HbA1c targets, kidney function, and response to treatment
- Renal Monitoring: Kidney function should be assessed before starting therapy and periodically during treatment, as dose adjustment may be required based on eGFR (estimated glomerular filtration rate)
Always follow your doctor's prescribed dose and duration. Never self-adjust the dose.
Common Side Effects Megnumet-50/500 is generally well tolerated. Reported side effects may include:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain or stomach discomfort
- Hypoglycemia (low blood sugar) — risk is higher when used in combination with other antidiabetic drugs or insulin; symptoms include sweating, dizziness, shakiness, and rapid heartbeat
Seek immediate medical attention if you experience:
- Unusual muscle pain, weakness, difficulty breathing, or stomach pain — possible signs of lactic acidosis, a rare but serious condition associated with Metformin
- Severe and persistent joint pain — a rare side effect associated with DPP-4 inhibitors like Sitagliptin
- Signs of pancreatitis such as severe and persistent abdominal pain radiating to the back, with or without vomiting
Report any persistent or worsening side effects to your doctor promptly.
Common Interactions Inform your doctor or pharmacist about all medications, supplements, and herbal products you are currently taking. Notable interactions include:
- Iodinated Contrast Media — Metformin must be temporarily discontinued before procedures involving iodinated contrast dye (e.g., CT scans) due to increased risk of acute kidney injury and lactic acidosis; restart only after kidney function is confirmed normal
- Alcohol — Significantly increases the risk of lactic acidosis with Metformin and may also cause unpredictable blood sugar fluctuations; strictly avoid during treatment
- Cimetidine (acid reducer) — May increase Metformin blood levels by reducing its renal clearance, potentially increasing the risk of side effects
- Diuretics (e.g., Furosemide, Hydrochlorothiazide) — May affect kidney function and alter the clearance of Sitagliptin; close monitoring is advised
- Other Antidiabetic Drugs or Insulin — Concurrent use may significantly increase the risk of hypoglycemia; regular blood glucose monitoring and possible dose adjustments are required
- Corticosteroids and Sympathomimetics (e.g., Prednisolone, Epinephrine) — May counteract the blood sugar-lowering effect of this combination, leading to elevated glucose levels; additional monitoring and therapy adjustment may be needed
Special Instructions
| Condition | Guidance |
|---|---|
| 🤰 Pregnancy | Megnumet-50/500 is highly unsafe during pregnancy. It may cause serious harm to the unborn baby, including birth defects and risk of pregnancy loss. Insulin is the recommended and safer alternative for managing blood sugar during pregnancy. Consult your doctor immediately if you are pregnant or planning to conceive. |
| 🤱 Breastfeeding | This medication is unsafe during breastfeeding. Both Sitagliptin and Metformin may pass into breast milk and could potentially harm the nursing infant. Consult your doctor for a suitable and safer alternative while breastfeeding. |
| 🍺 Alcohol | Alcohol is strictly unsafe with this medication. It significantly increases the risk of lactic acidosis associated with Metformin and may cause unpredictable fluctuations in blood sugar levels. Avoid alcohol completely during the course of treatment. |
| 🚗 Driving | It is not clearly established whether this tablet directly affects the ability to drive. However, if used alongside other antidiabetic medicines, the risk of hypoglycemia may impair concentration and reaction time. Always check your blood glucose before driving and avoid driving if you feel dizzy, confused, or unwell. |
| 🫀 Liver Disease | Use with caution in patients with liver disease. Impaired liver function can affect the metabolism of both components and increases the risk of lactic acidosis with Metformin. This medication is generally not recommended in patients with significant hepatic impairment. Consult your doctor for appropriate alternatives. |
| 🫘 Kidney Disease | Use with caution in patients with kidney disease. Metformin is contraindicated in significant renal impairment due to the risk of lactic acidosis from drug accumulation. Sitagliptin dose may also require adjustment based on kidney function. Kidney function must be assessed before starting therapy and monitored regularly throughout treatment. |
Mechanism of Action Megnumet-50/500 combines two antidiabetic medicines that work through distinct and complementary mechanisms to achieve comprehensive blood glucose control:
Sitagliptin (DPP-4 Inhibitor): Inhibits the enzyme Dipeptidyl Peptidase-4 (DPP-4), which is responsible for the rapid breakdown of incretin hormones (GLP-1 and GIP) in the body. By blocking this enzyme, Sitagliptin increases and prolongs the activity of these natural incretin hormones. Incretins stimulate the pancreatic beta cells to produce and release more insulin in response to meals, and simultaneously suppress glucagon secretion from pancreatic alpha cells — reducing excess glucose release from the liver. This mechanism is glucose-dependent, meaning it primarily acts when blood sugar is elevated, significantly lowering the risk of hypoglycemia when used alone
Metformin (Biguanide): Works through three well-established complementary actions — it suppresses excess hepatic glucose production (gluconeogenesis and glycogenolysis), slows the rate of glucose absorption from the intestines into the bloodstream, and enhances peripheral insulin sensitivity, promoting greater glucose uptake and utilization by muscles and fat tissue. Metformin improves both fasting and postprandial glucose levels without directly stimulating insulin secretion, thereby carrying a low standalone risk of hypoglycemia
Together, they deliver a multi-targeted approach to blood sugar control — enhancing natural insulin response, suppressing excess glucagon activity, reducing hepatic glucose output, and improving cellular insulin sensitivity — making this combination particularly effective and well-tolerated for long-term Type 2 diabetes management.
Instructions to Take
- Take this tablet with meals to reduce the risk of gastrointestinal side effects such as nausea and stomach discomfort
- Swallow the tablet whole with a full glass of water — do not crush or chew unless specifically advised
- Take it at the same times each day to maintain consistent blood glucose control throughout the day
- Monitor your blood sugar regularly as advised by your doctor and maintain a record to share at follow-up visits
- Always carry a fast-acting sugar source (glucose tablets, fruit juice, or sugar) in case of a hypoglycemic episode, particularly if you are also on other antidiabetic medicines
- Inform your doctor before any surgical procedure or imaging test involving contrast dye — Metformin may need to be temporarily stopped beforehand
- Do not discontinue this medicine abruptly without consulting your doctor — diabetes requires continuous, uninterrupted management
- If you miss a dose, take it as soon as you remember with your next meal. If it is almost time for the next dose, skip the missed dose — do not double up
- Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children
This information is intended for general reference purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, changing, or stopping any medication.
